Market Research Logo

Pharmaceuticals in North America

Pharmaceuticals in North America

Summary

Pharmaceuticals in North America industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the North America pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
  • The North American pharmaceuticals market had total revenues of $444.3bn in 2017, representing a compound annual growth rate (CAGR) of 7.6% between 2013 and 2017.
  • Obesity is an increasingly bigger problem in North America which means a large demand for medication for its co-morbidities - heart disease and diabetes.
  • The US is by far the largest market in the region, and maintains good growth consistently despite its developed nature due to the very strong private health sector.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in North America
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in North America
  • Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the North America pharmaceuticals market with five year forecasts
Reasons to buy
  • What was the size of the North America pharmaceuticals market by value in 2017?
  • What will be the size of the North America pharmaceuticals market in 2022?
  • What factors are affecting the strength of competition in the North America pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitiors in North America's pharmaceuticals market?


Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
AstraZeneca PLC
Johnson & Johnson
Merck & Co., Inc.
Pfizer Inc.
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine
List of Tables
Table 1: North America pharmaceuticals market value: $ billion, 2013-17
Table 2: North America pharmaceuticals market geography segmentation: $ billion, 2017
Table 3: North America pharmaceuticals market share: % share, by value, 2017
Table 4: North America pharmaceuticals market value forecast: $ billion, 2017-22
Table 5: AstraZeneca PLC: key facts
Table 6: AstraZeneca PLC: key financials ($)
Table 7: AstraZeneca PLC: key financial ratios
Table 8: Johnson & Johnson: key facts
Table 9: Johnson & Johnson: key financials ($)
Table 10: Johnson & Johnson: key financial ratios
Table 11: Merck & Co., Inc.: key facts
Table 12: Merck & Co., Inc.: key financials ($)
Table 13: Merck & Co., Inc.: key financial ratios
Table 14: Pfizer Inc.: key facts
Table 15: Pfizer Inc.: key financials ($)
Table 16: Pfizer Inc.: key financial ratios
List of Figures
Figure 1: North America pharmaceuticals market value: $ billion, 2013-17
Figure 2: North America pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 3: North America pharmaceuticals market share: % share, by value, 2017
Figure 4: North America pharmaceuticals market value forecast: $ billion, 2017-22
Figure 5: Forces driving competition in the pharmaceuticals market in North America, 2017
Figure 6: Drivers of buyer power in the pharmaceuticals market in North America, 2017
Figure 7: Drivers of supplier power in the pharmaceuticals market in North America, 2017
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in North America, 2017
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in North America, 2017
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in North America, 2017
Figure 11: AstraZeneca PLC: revenues & profitability
Figure 12: AstraZeneca PLC: assets & liabilities
Figure 13: Johnson & Johnson: revenues & profitability
Figure 14: Johnson & Johnson: assets & liabilities
Figure 15: Merck & Co., Inc.: revenues & profitability
Figure 16: Merck & Co., Inc.: assets & liabilities
Figure 17: Pfizer Inc.: revenues & profitability
Figure 18: Pfizer Inc.: assets & liabilities

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report